Eton Pharmaceuticals (ETON) Q4 Revenue Surges 82.9% YoY to $21.3M, EPS Climbs 266.7% 2 days ago Eton Pharmaceuticals Q4 GAAP EPS of $0.05 missed the $0.20 estimate by 75%, though revenue of $21.3M topped consensus and… Canadian Solar 2025 Financial Review 2 days ago Canadian Solar reports Q4 loss of $1.66/share, 84.5% wider than estimates, as revenue of $1.20B misses consensus by $150M. Intellicheck (IDN) EPS Soars 114.5% to $0.08, Crushing $0.03 Estimate on Revenue Growth 2 days ago Intellicheck posts $0.08 EPS vs $0.03 estimate, revenue up 12% YoY to $6.6M as profitability inflection gains momentum. Arcos Dorados 2025 Financial Review 2 days ago Arcos Dorados Q4 EPS of $0.13 missed estimates by 35.7% despite revenue topping consensus at $1.27 billion, up 10.7% year-over-year. LexinFintech Holdings Ltd. 2025 Financial Review 2 days ago LexinFintech posts $1.38 adjusted EPS for Q4 2025, matching prior quarter as shares trade near 52-week lows. Movado Group FY 2026 Financial Results 2 days ago Movado Group posts Q4 EPS of $0.57, beating the $0.54 estimate by 5.6%, as revenue of $191.6M tops consensus by… Caleres Q4 & FY25 Financial Review 2 days ago Caleres posts $0.38 EPS, beating estimates by 55.5% as margins hold despite sequential revenue decline to $639.2M. GrowGeneration 2025 Financial Results Breakdown 2 days ago GrowGeneration posts wider-than-expected Q4 loss of $0.12 per share despite revenue topping estimates at $37.8M. Torrid Holdings Inc.: Fiscal 2025 Financial Review 2 days ago Torrid narrows Q4 loss to $0.06 per share vs $0.07 estimate; revenue of $236.2M tops consensus by 2.2% despite balance… Greystone Housing Impact Investors LP 2025 Financial Review 2 days ago Greystone Housing posts $0.17 loss vs $0.60 estimate as Q4 revenue of $17.2M misses consensus by 27.5%, shares near 52-week… Next» « Previous